277 related articles for article (PubMed ID: 28279977)
21. SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions.
Tripathi BK; Anderman MF; Qian X; Zhou M; Wang D; Papageorge AG; Lowy DR
J Cell Biol; 2019 Sep; 218(9):3060-3076. PubMed ID: 31308216
[TBL] [Abstract][Full Text] [Related]
22. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
[TBL] [Abstract][Full Text] [Related]
23. Decreased PKG transcription mediated by PI3K/Akt/FoxO1 pathway is involved in the development of nitroglycerin tolerance.
An YM; Li YJ; Zhang CL; Cong X; Gao YS; Wu LL; Dou D
Biochem Biophys Res Commun; 2019 Jan; 508(4):1195-1201. PubMed ID: 30554658
[TBL] [Abstract][Full Text] [Related]
24. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
25. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
26. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the phosphatidylinositol 3-kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells.
Achiwa Y; Hasegawa K; Udagawa Y
Biosci Biotechnol Biochem; 2007 Jan; 71(1):31-7. PubMed ID: 17213663
[TBL] [Abstract][Full Text] [Related]
28. TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.
Hill R; Madureira PA; Ferreira B; Baptista I; Machado S; Colaço L; Dos Santos M; Liu N; Dopazo A; Ugurel S; Adrienn A; Kiss-Toth E; Isbilen M; Gure AO; Link W
Nat Commun; 2017 Mar; 8():14687. PubMed ID: 28276427
[TBL] [Abstract][Full Text] [Related]
29. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer.
Park H; Kim Y; Sul JW; Jeong IG; Yi HJ; Ahn JB; Kang JS; Yun J; Hwang JJ; Kim CS
Prostate; 2015 Nov; 75(15):1747-59. PubMed ID: 26250606
[TBL] [Abstract][Full Text] [Related]
30. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
31. Nuclear Export of FoxO1 Is Associated with ERK Signaling in β-Cells Lacking Insulin Receptors.
Mezza T; Shirakawa J; Martinez R; Hu J; Giaccari A; Kulkarni RN
J Biol Chem; 2016 Oct; 291(41):21485-21495. PubMed ID: 27535223
[TBL] [Abstract][Full Text] [Related]
32. Relative importance of phosphatidylinositol-3 kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK3/1) signaling during maturational steroid-induced meiotic G2-M1 transition in zebrafish oocytes.
Das D; Nath P; Pal S; Hajra S; Ghosh P; Maitra S
Zygote; 2018 Feb; 26(1):62-75. PubMed ID: 29229010
[TBL] [Abstract][Full Text] [Related]
33. IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis.
Li JH; McMillan RH; Begum A; Gocke CB; Matsui W
Pancreas; 2019 Jan; 48(1):94-98. PubMed ID: 30540680
[TBL] [Abstract][Full Text] [Related]
34. Gandouling alleviates nerve injury through PI3K/Akt/FoxO1 and Sirt1/FoxO1 signaling pathway to inhibit autophagy in the rats model of Wilson's disease.
Chen L; Xu W; Zhang Y; Chen H; Han Y
Brain Behav; 2023 Dec; 13(12):e3325. PubMed ID: 38010098
[TBL] [Abstract][Full Text] [Related]
35. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
[TBL] [Abstract][Full Text] [Related]
36. AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins.
Saline M; Badertscher L; Wolter M; Lau R; Gunnarsson A; Jacso T; Norris T; Ottmann C; Snijder A
J Biol Chem; 2019 Aug; 294(35):13106-13116. PubMed ID: 31308176
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase.
Gesmundo I; Di Blasio L; Banfi D; Villanova T; Fanciulli A; Favaro E; Gamba G; Musuraca C; Rapa I; Volante M; Munegato S; Papotti M; Gontero P; Primo L; Ghigo E; Granata R
Cancer Lett; 2019 May; 449():252-262. PubMed ID: 30790678
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
39. mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1.
Wang Q; Ren J
Pharmacol Res; 2016 Sep; 111():357-373. PubMed ID: 27363949
[TBL] [Abstract][Full Text] [Related]
40. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; Luo J; He J; Zheng P; Yu J
Br J Nutr; 2018 Apr; 119(7):727-733. PubMed ID: 29569540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
